Marker Therapeutics, Inc. (MRKR)
1.16
-0.03
(-2.52%)
USD |
NASDAQ |
Sep 25, 15:35
Marker Therapeutics Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 18.78M |
| March 31, 2023 | -0.1126M |
| December 31, 2022 | -0.1273M |
| September 30, 2022 | -0.0994M |
| June 30, 2022 | -2.266M |
| March 31, 2022 | -2.452M |
| December 31, 2021 | -0.3498M |
| September 30, 2021 | -2.001M |
| June 30, 2021 | -0.3396M |
| March 31, 2021 | -0.4411M |
| December 31, 2020 | -3.386M |
| September 30, 2020 | -3.114M |
| June 30, 2020 | -3.828M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0998M |
| December 31, 2019 | -0.0129M |
| September 30, 2019 | -0.0567M |
| June 30, 2019 | -0.0823M |
| March 31, 2019 | -0.2231M |
| December 31, 2018 | -0.1477M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.716M |
| Free Cash Flow | -9.756M |
| Free Cash Flow Per Share (Quarterly) | -0.1924 |
| Free Cash Flow to Equity (Quarterly) | -3.716M |
| Free Cash Flow to Firm (Quarterly) | -3.716M |
| Free Cash Flow Yield | -46.69% |